Id4 has been shown to inhibit glioma invasion in vitro by inhibiting MMP2 expression via an inhibitory interaction with Twist1 [236], a class II bHLH transcription factor that is highly expressed in GBM and is crucial for MMP2 expression [237, 238]. Here, MMP2 is linked to central nervous system cancer.